Hughes T R, Piddlesden S J, Williams J D, Harrison R A, Morgan B P
Department of Medical Biochemistry, University of Wales College of Medicine, Heath Park, Cardiff, U.K.
Biochem J. 1992 May 15;284 ( Pt 1)(Pt 1):169-76. doi: 10.1042/bj2840169.
The membrane attack complex (MAC) of complement in humans is regulated by several membrane-bound proteins; however, no such proteins have so far been described in other species. Here we report the isolation and characterization of a rat erythrocyte membrane glycoprotein of molecular mass 21 kDa which inserts into cell membranes and is a potent inhibitor of the rat MAC. This protein, here called rat inhibitory protein (RIP), was first partially purified by column chromatography from a butanol extract of rat erythrocyte membranes. Monoclonal antibodies (Mabs) were raised against RIP and used for its affinity purification. Affinity-purified RIP was shown to inhibit in a dose-dependent manner the cobra venom factor (CVF)-mediated 'reactive' lysis of guinea pig erythrocytes by rat complement. Conversely, the anti-RIP MAbs 6D1 and TH9 were shown to markedly enhance the CVF-mediated lysis of rat erythrocytes by rat complement. RIP acted late in the assembly of the MAC (at or after the C5b-8 stage) and was releasable from the membranes of rat erythrocytes by phosphatidylinositol-specific phospholipase C. These features, together with its size, deglycosylation pattern and N-terminal amino acid sequence, lead us to conclude that RIP is the rat homologue of the human MAC-inhibitory protein CD59 antigen.
人类补体的膜攻击复合物(MAC)受多种膜结合蛋白调控;然而,目前尚未在其他物种中发现此类蛋白。在此,我们报告了一种分子量为21 kDa的大鼠红细胞膜糖蛋白的分离与特性,该蛋白可插入细胞膜,是大鼠MAC的强效抑制剂。这种蛋白,我们在此称为大鼠抑制蛋白(RIP),最初通过柱色谱法从大鼠红细胞膜的丁醇提取物中部分纯化得到。制备了针对RIP的单克隆抗体(Mab)并用于其亲和纯化。经证明,亲和纯化的RIP能以剂量依赖方式抑制眼镜蛇毒因子(CVF)介导的大鼠补体对豚鼠红细胞的“反应性”溶解。相反,抗RIP单克隆抗体6D1和TH9能显著增强CVF介导的大鼠补体对大鼠红细胞的溶解。RIP在MAC组装后期起作用(在C5b - 8阶段或之后),并且可通过磷脂酰肌醇特异性磷脂酶C从大鼠红细胞膜上释放。这些特征,连同其大小、去糖基化模式和N端氨基酸序列,使我们得出结论,RIP是人类MAC抑制蛋白CD59抗原的大鼠同源物。